Partner With Us
How device manufacturers, pharma and biotech, providers and payers, and research institutions work with NeuTigers — engagement models and a clear path from discovery to deployment.
Who we work with
Device manufacturers & OEMs
Your devices already capture rich physiological signal; NeuTigers turns that signal into differentiated health features that run on the device itself. We develop, validate and optimize compact models for your hardware — as our multi-year health and wellness partnership with Samsung (2023) reflects — so you can offer health intelligence without building a clinical AI pipeline from scratch. Typical engagements: co-developed health features, model licensing and joint validation on your sensor stack.
Pharma & biotech
Continuous, real-world physiological data can sharpen how you identify, monitor and support patients — and methods like SCouT target more time- and subject-efficient clinical studies. With NeuTigers you can run decentralized data collection on everyday wearables, build digital measures around your therapeutic areas, and sponsor validation studies in indications such as diabetes, sickle cell disease and women's health. Typical engagements: sponsored studies, co-developed digital measures and program partnerships.
Providers & payers
Earlier detection and continuous monitoring of chronic and rare conditions can help intervene before crises and hospitalizations — the aim of our AP-HP collaborations in sickle cell disease and type 2 diabetes. NeuTigers offers programs with clearly labeled evidence maturity that can be piloted within your populations and integrated into care pathways. Typical engagements: pilots, validation collaborations in your care setting and program integration.
Research & clinical institutions
Our clinical progress is built on institutional collaborations — AP-HP, Genopole and CHSF among them. We bring the model-development platform, edge deployment capability and decentralized data-collection tooling; you bring clinical expertise, populations and study leadership. Typical engagements: joint studies, co-authored publications and publicly supported programs (e.g., France 2030).
Engagement models
- Co-development of new disease programs or device features
- Technology and model licensing
- Sponsored validation studies
- Integration of existing programs into partner devices, products or care pathways
- Geographic commercialization partnerships
How an engagement runs
- Discovery — align on the clinical problem, audience and success criteria.
- Feasibility — assess data availability, device fit and technical viability.
- Data & clinical plan — define data collection, governance and, where needed, the study protocol.
- Model development — build and iterate compact, edge-optimized models on StarDeep.
- Validation — retrospective and/or prospective evaluation against the agreed criteria.
- Deployment — integrate the validated models into the target device and care workflow.
Start the conversation
Write to info@neutigers.com. To help us route your inquiry quickly, please include: which audience above best describes you, the use case or indication you have in mind, your geography, your expected timeline, and the type of engagement you are considering.